Petros Pharmaceuticals, Inc. (PTPI) › EPS (Diluted)Petros Pharmaceuticals, Inc. (PTPI) — EPS (Diluted)Annual figures by period end, from SEC filings.2020-12-31: $-3.852021-12-31: $-8.252022-12-31: $-9.682023-12-31: $-6.352024-12-31: $-83.472025-12-31: $-1.56$-1.562020-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-1.56—2026-04-15From 2025-01-012024-12-31$-83.47—2026-04-15From 2024-01-012023-12-31$-6.35—2025-03-31From 2023-01-012022-12-31$-9.68—2024-04-01From 2022-01-012021-12-31$-8.25—2023-03-31From 2021-01-012020-12-31$-3.85—2022-03-31From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)